Hunan Provincial People's Government Vice Governor Jiang Tufei and his entourage came to Zhongnan Yuanpin Stem Cell Science and Technology Park for research!
On December 18, Hunan Provincial People's Government Vice Governor Jiang Dafei investigated the biomedical and medical device industry chain in Changsha. He emphasized that it is necessary to base on the actual development of Hunan's biopharmaceutical industry and medical device industry, deploy the innovation chain around the industrial chain, promote the acceleration of the whole process and the empowerment of the whole chain, and make every effort to promote the high-quality development of the biopharmaceutical industry.
Jiang Dafei has come to Jiuzhitang Co., Ltd, Hunan Fangsheng Pharmaceutical Co., Ltd, Derong Medical Technology Co., Ltd, Yuanpin Cellular Biotechnology Group Co., Ltd and other enterprises and units, inspecting the production workshop, research and development platforms, etc., and gaining an in-depth understanding of the biopharmaceutical and medical device industry product research and development, platform construction, industry chain cooperation, market development, capital investment and personnel training.
During the research process of Yuanpin Bio, Vice Governor Jiang Dafei and his entourage listened to the detailed introduction about the construction of cell and regenerative medicine whole industry chain science and technology park, inspected and visited the core modules such as Hunan Cell Tissue Bank, Hunan Cell Preparation Center, Stem Cell and Regenerative Medicine Research Institute, and Changsha Stem Cell and Regenerative Medicine Industrial Technology Research Institute, etc., and gained a deeper understanding of the operation of the whole industry platform of Zhongnan Yuanpin Stem Cell Science and Technology Park, and the infrastructure construction of the stem cell industry, the production platform, and the production platform. As well as the stem cell industry infrastructure, production and preparation technology, cell drugs and technology research and development and other specifics.
Jiang Dufei emphasized that it is necessary to base on the actual development of Hunan's biomedical industry and medical device industry, deploy the innovation chain around the industrial chain, promote the acceleration of the whole process and the empowerment of the whole chain, and make every effort to promote the high-quality development of the biomedical industry.
Jiang Dufei pointed out that we should promote the “basic research, incubation and transformation, clinical trials, review and approval, production, promotion and application” of the whole process of acceleration and the whole chain of empowerment, aiming at the frontiers of life sciences, increase investment in R & D, improve the construction of key technology platforms, and scientific and technological innovation to lead the innovation of the industry. It is necessary to strengthen the research and development, cultivation, publicity and promotion of key varieties of the industrial chain, accurately match the market demand, and create a favorable environment for enterprises to grow bigger and stronger. It is necessary to deepen the medical, health insurance, pharmaceutical linkage reform and collaborative governance, improve the mechanism to support the development of innovative drugs and medical devices, promote high-level open cooperation, and promote the optimization and upgrading of the whole industrial chain.
Participating in this research are also the deputy secretary-general of the provincial people's government, Chen Jing, the director of the provincial health commission, Li Xiaosong, the secretary of the provincial people's government general office of the third division director Li Xiaoya and other leaders.
Biomedical industry is one of the 20 industrial emerging advantageous industry chain in Hunan Province, and the data shows that the annual output value of biomedical industry in Hunan Province will exceed 350 billion yuan in 2022, with the growth rate ranking the first among 14 industrial sectors. Hunan Province to accelerate the development of new quality productivity, the biopharmaceutical industry bears the brunt.
The Zhongnan Yuanpin Stem Cell Science and Technology Park constructed by Yuanpin Bio has achieved remarkable platform construction results and scientific research achievements since it officially went into operation in 2019. The park has built a whole industry chain system from basic research to key technology development, to product development and clinical application, and completed a comprehensive cell industrialization platform integrating research and development, pilot plant, production and technical service, thus further constructing a “research-transformation-incubation-acceleration” full-cycle industry. In order to further build the innovation engine of “research-transformation-incubation-acceleration” for the high-quality development of the whole cycle of industry. The company focuses on the research and development of stem cell drugs and clinical technology research and development projects and has made a major breakthrough, which is expected to fill the clinical gaps of Class I stem cell innovative drugs in Hunan Province.
In the future, Yuanpin Bio will continue to actively explore new modes of industrial development, comprehensively enhance the level of scientific and technological innovation in the biomedical industry track, boost the high-quality development of industries in the field of health, and inject surging kinetic energy into the new quality productivity.
